Literature DB >> 8436261

Visceral fat deposition is seen in patients with insulinoma.

H Inadera, S Ito, Y Ishikawa, M Shinomiya, K Shirai, Y Saito, S Yoshida.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8436261     DOI： 10.1007/bf00399101

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Patients with insulinoma show insulin resistance in the absence of arterial hypertension.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

2.  Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance.

Authors:  I Cusin; J Terrettaz; F Rohner-Jeanrenaud; N Zarjevski; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

3.  Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

Authors:  S Fujioka; Y Matsuzawa; K Tokunaga; S Tarui
Journal:  Metabolism       Date:  1987-01       Impact factor: 8.694

4.  Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography.

Authors:  G Enzi; M Gasparo; P R Biondetti; D Fiore; M Semisa; F Zurlo
Journal:  Am J Clin Nutr       Date:  1986-12       Impact factor: 7.045

5.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

6.  A novel technique for the determination of body fat by computed tomography.

Authors:  K Tokunaga; Y Matsuzawa; K Ishikawa; S Tarui
Journal:  Int J Obes       Date:  1983
  6 in total
  1 in total

Review 1.  Non-surgical ablative therapies for inoperable benign insulinoma.

Authors:  C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo
Journal:  J Endocrinol Invest       Date:  2017-07-28       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.